Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.

15/11/2022
/ Publications
/
IMPT
IMRT

This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...

Proton Beam Therapy for Esophageal Cancer.

15/11/2022
/ Publications
/
Clinical Trial

A latest review examined the existing of PBT for locally advanced esophageal cancer, including dosimetric comparative studies, early clinical outcome...

Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.

15/11/2022
/ Publications
/
Hypofractionation

This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...

Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.

15/11/2022
/ Publications
/
IMPT
IMRT

163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.

15/11/2022
/ Publications

A study by the Samsung group Korea reported the clinical outcomes of 168 patients with early stage of NSCLC treated by photon SBRT and 34 with proton SBRT...

Lung treatment with pencil beam scanner at the Texas Center of Proton Therapy

01/01/2017
/ Event
/
Pencil Beam Scanning - PBS
Proton therapy center

The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center...

Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade.

15/11/2022
/ Publications
/
Survival

This study by the NCC group Korea reported results of PBT as an initial treatment for 46 treatment-naïve hepatocellular carcinoma (HCC) patients. With a median...

The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer

15/11/2022
/ Publications

A study by the Samsung group Korea reported outcomes of 49 patients with pancreatic cancer (≥80% patients locally advanced unresectable disease) treated with...

Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.

15/11/2022
/ Publications

This study reports 3-year outcomes of the Proton Collaborative Group phase II trial (PCG BRE007-12) that recruited women ≥ 50 years with node-negative, estrogen...

Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial.

15/11/2022
/ Publications
/
FLASH Therapy

Published in JAMA, this is the results of the FAST-01 proton FLASH trial. This trial was set to test the clinical workflow feasibility, treatment related...